Nausea, Mild Stomach Pain, or Gas These conditions tend to come with the territory for GLP-1 users, especially during the dose titration period where you escalate toward your specific target dosage
The cardiovascular outcomes trial SUSTAIN-6, published in the New England Journal of Medicine, demonstrated cardiovascular safety in a population where many participants were receiving antiplatelet therapy
The drugs work by mimicking a natural hormone, glucagon-like peptide-1, which slows down the passage of food through the stomach, making people feel full for longer
The working theory is that GLP-1s protect the heart through a combination of better metabolic control, lower inflammation, and direct vascular and cardiac benefits
Wang S, Xiong Y, Zhao Q, Song H, Yi P, Liu C